Living with cancer of unknown primary: a support study
Part of Cancer clinical trials.
This trial looks at the experiences of people with cancer of unknown primary (CUP) and their caregivers. It aims to understand what it's like to live without a clear diagnosis and how to improve support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of cancer of unknown primary (CUP) or you care for someone who does.
- You are 18 years old or older.
- You are able to give informed consent (understand what the study involves and agree to take part).
- You are not too unwell to participate, as judged by the clinical team.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a program to help people cope emotionally after finishing curative cancer treatment. It may reduce distress and improve well-being through online tools.
This is an observational study that follows young adults with a confirmed cancer diagnosis to learn more about their experience and care. It does not test a new drug, but your information may help improve future cancer treatment and support.
This study follows children, teens, and young adults with cancer and people who have completed treatment. It aims to better understand cancer care over time and what affects outcomes, which may help improve future treatment and follow-up.
This British Columbia study looks at how well different cancer treatments work in real life when doctors aren't sure which option is best. You and your doctor would choose a treatment, and researchers will track your results to help others.
This trial tests a palliative care program to improve wellbeing for people with advanced cancer who are moving from hospital treatment to community-based care. It aims to provide extra support during this transition.
This trial is for people with cancer of unknown primary (CUP), meaning cancer that started in an unknown place in the body. It aims to use advanced genomic testing (looking at your tumor's DNA) on your stored tumor sample and blood to find clues about where the cancer began and possible treatment options.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.